Cargando…
Strategies to identify individuals with monogenic diabetes: results of an economic evaluation
OBJECTIVES: To evaluate and compare the lifetime costs associated with strategies to identify individuals with monogenic diabetes and change their treatment to more appropriate therapy. DESIGN: A decision analytical model from the perspective of the National Health Service (NHS) in England and Wales...
Autores principales: | Peters, Jaime L, Anderson, Rob, Shields, Beverley, King, Sophie, Hudson, Michelle, Shepherd, Maggie, McDonald, Timothy James, Pearson, Ewan, Hattersley, Andrew, Hyde, Chris |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7150598/ https://www.ncbi.nlm.nih.gov/pubmed/32193268 http://dx.doi.org/10.1136/bmjopen-2019-034716 |
Ejemplares similares
-
Identifying clinical criteria to predict Type 1 diabetes, as defined by absolute insulin deficiency: a systematic review protocol
por: Shields, Beverley M, et al.
Publicado: (2012) -
Development and validation of multivariable clinical diagnostic models to identify type 1 diabetes requiring rapid insulin therapy in adults aged 18–50 years
por: Lynam, Anita, et al.
Publicado: (2019) -
Can clinical features be used to differentiate type 1 from type 2 diabetes? A systematic review of the literature
por: Shields, Beverley M, et al.
Publicado: (2015) -
Development of an economic evaluation of diagnostic strategies: the case of monogenic diabetes
por: Peters, Jaime L, et al.
Publicado: (2013) -
TriMaster: randomised double-blind crossover study of a DPP4 inhibitor, SGLT2 inhibitor and thiazolidinedione as second-line or third-line therapy in patients with type 2 diabetes who have suboptimal glycaemic control on metformin treatment with or without a sulfonylurea—a MASTERMIND study protocol
por: Angwin, Catherine, et al.
Publicado: (2020)